Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	37.95	36.65	26.57
Graham Fair Price	-28.97	9.36	13.17
PEG	57.55	-0.66	-1.57
Price/Book	-5.14	1.96	2.06
Price/Cash Flow	386.14	118.31	24.34
Prices/Earnings	91.01	33.22	17.39
Price/Sales	22.76	5.73	4.67
Price/FCF	386.14	118.31	24.34
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.32	0.15	0.16
Operating Margin	-40.87	0.05	0.09
ROA	-49.26	< 0.005	0.02
ROE	0.03	0.01	-50.34
ROIC	0.02	0.01	-50.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.15	-52.87
Dividends QOQ	0.05	< 0.005	-99.10
EBIT QOQ	-0.05	-0.54	-1032.03
EPS QOQ	-0.11	-0.50	-350.00
FCF QOQ	6.59	-0.80	-87.81
Revenue QOQ	-0.04	-0.22	-474.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.02	25.60	6.56
Days Sales Outstanding (DSO)	59.06	72.10	22.09
Inventory Turnover	3.75	3.52	-6.16
Debt/Capitalization	0.25	0.24	-4.39
Quick Ratio	1.98	2.05	3.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.12	16.25	0.79
Cash	6.49	6.39	-1.46
Capex	-0.97	-0.39	59.60
Free Cash Flow	1.37	0.27	-80.33
Revenue	7.13	5.55	-22.12
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.31	2.34	1.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.83	0.76	-8.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating